Clearside Biomedical Inc (CLSD)
1.03
+0.02
(+1.98%)
USD |
NASDAQ |
Nov 04, 16:00
1.06
+0.03
(+2.91%)
After-Hours: 20:00
Clearside Biomedical Market Cap: 76.99M for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 75.49M |
| October 31, 2024 | 76.24M |
| October 30, 2024 | 77.74M |
| October 29, 2024 | 78.48M |
| October 28, 2024 | 82.22M |
| October 25, 2024 | 82.22M |
| October 24, 2024 | 82.22M |
| October 23, 2024 | 84.84M |
| October 22, 2024 | 88.57M |
| October 21, 2024 | 98.66M |
| October 18, 2024 | 85.96M |
| October 17, 2024 | 85.96M |
| October 16, 2024 | 83.72M |
| October 15, 2024 | 82.97M |
| October 14, 2024 | 88.95M |
| October 11, 2024 | 92.68M |
| October 10, 2024 | 98.66M |
| October 09, 2024 | 97.92M |
| October 08, 2024 | 110.62M |
| October 07, 2024 | 118.10M |
| October 04, 2024 | 108.38M |
| October 03, 2024 | 99.41M |
| October 02, 2024 | 100.16M |
| October 01, 2024 | 100.16M |
| September 30, 2024 | 94.93M |
| Date | Value |
|---|---|
| September 27, 2024 | 86.70M |
| September 26, 2024 | 85.21M |
| September 25, 2024 | 83.72M |
| September 24, 2024 | 85.58M |
| September 23, 2024 | 89.69M |
| September 20, 2024 | 97.92M |
| September 19, 2024 | 95.67M |
| September 18, 2024 | 97.17M |
| September 17, 2024 | 97.54M |
| September 16, 2024 | 97.92M |
| September 13, 2024 | 91.94M |
| September 12, 2024 | 100.91M |
| September 11, 2024 | 97.92M |
| September 10, 2024 | 84.46M |
| September 09, 2024 | 79.23M |
| September 06, 2024 | 72.50M |
| September 05, 2024 | 69.32M |
| September 04, 2024 | 71.76M |
| September 03, 2024 | 74.75M |
| August 30, 2024 | 75.49M |
| August 29, 2024 | 75.49M |
| August 28, 2024 | 74.75M |
| August 27, 2024 | 75.49M |
| August 26, 2024 | 75.49M |
| August 23, 2024 | 76.24M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
41.56M
Minimum
Nov 15 2019
428.25M
Maximum
Aug 27 2021
117.56M
Average
89.14M
Median
Jan 19 2023
Market Cap Benchmarks
| Viking Therapeutics Inc | 7.037B |
| Arcus Biosciences Inc | 1.422B |
| Crinetics Pharmaceuticals Inc | 4.548B |
| Biomea Fusion Inc | 320.35M |
| NovaBay Pharmaceuticals Inc | 3.811M |
Market Cap Related Metrics
| PS Ratio | 9.205 |
| Price | 1.03 |
| Earnings Yield | -48.54% |